Trials / Completed
CompletedNCT01390701
Blood Pressure Lowering Effect of Transcutaneous Electrical Nerve Stimulation
Blood Pressure Lowering Effect of Low-frequency Transcutaneous Electrical Nerve Stimulation and Felodipin
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Sahlgrenska University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the blood pressure reducing property of transcutaneous electrical nerve stimulation with the blood pressure reducing drug felodipin.
Detailed description
Hypertension is a major risk factor for development of several vascular complications and is common world wide. Drug treatment is often necessary to achieve adequate blood pressure reduction but blood pressure control in studied countries is unsatisfactory low. Reasons for failure in treatment are several. Among others reasons intolerable side-effects may prevent successful treatment irrespective of the number of drugs. Transcutaneous electrical nerve stimulation (TENS) constitutes no risk of interaction with pharmacological agents and previous studies have reported blood pressure reduction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | transcutaneous electrical nerve stimulation | 30 min of bi-daily low-frequency transcutaneous electrical nerve stimulation on the upper extremities. Duration: 28+-4 days. |
| DRUG | felodipin | 2,5mg of felodipin once daily. Duration: 28+-4 days. |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2011-07-11
- Last updated
- 2011-07-11
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01390701. Inclusion in this directory is not an endorsement.